Liver study reveals how body handles new drug
NCT ID NCT07049939
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 23 times
Summary
This study looked at how the drug bomedemstat (MK-3543) moves through the body in people with mild or moderate liver problems compared to healthy volunteers. Nine participants received a single dose, and researchers measured drug levels in the blood. The goal was to understand if liver impairment changes how the drug is processed, which helps guide safe dosing.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATIC INSUFFICIENCY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Orlando Clinical Research Center ( Site 0001)
Orlando, Florida, 32809, United States
-
The Texas Liver Institute ( Site 0002)
San Antonio, Texas, 78215, United States
-
University of Miami ( Site 0003)
Miami, Florida, 33136, United States
Conditions
Explore the condition pages connected to this study.